Cargando…
Advances in cellular senescence in idiopathic pulmonary fibrosis (Review)
Idiopathic pulmonary fibrosis (IPF) is a progressive, irreversible and fatal interstitial lung disease of unknown cause, with a median survival of 2-3 years. Its pathogenesis is unclear and there is currently no effective treatment for IPF. Approximately two-thirds of patients with IPF are >60 ye...
Autores principales: | Han, Shan, Lu, Qiangwei, Liu, Xiaoqiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995810/ https://www.ncbi.nlm.nih.gov/pubmed/36911379 http://dx.doi.org/10.3892/etm.2023.11844 |
Ejemplares similares
-
Cellular Senescence in Idiopathic Pulmonary Fibrosis
por: Kellogg, D. L., et al.
Publicado: (2021) -
Biomarkers of cellular senescence in idiopathic pulmonary fibrosis
por: Aversa, Zaira, et al.
Publicado: (2023) -
Fibroblast Senescence in Idiopathic Pulmonary Fibrosis
por: Lin, Yifan, et al.
Publicado: (2020) -
Cellular Senescence: A Troy Horse in Pulmonary Fibrosis
por: Wan, Ruyan, et al.
Publicado: (2023) -
Cellular and Molecular Mechanisms in Idiopathic Pulmonary Fibrosis
por: Zhang, Yihang, et al.
Publicado: (2023)